It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
A new procedure can quickly and efficiently increase the length of human telomeres, the protective caps on the ends of chromosomes that are linked to aging and disease, according to scientists at the Stanford University School of Medicine.
Treated cells behave as if they are much younger than untreated cells, multiplying with abandon in the laboratory dish rather than stagnating or dying.
The procedure, which involves the use of a modified type of RNA, will improve the ability of researchers to generate large numbers of cells for study or drug development, the scientists say. Skin cells with telomeres lengthened by the procedure were able to divide up to 40 more times than untreated cells. The research may point to new ways to treat diseases caused by shortened telomeres.
Telomeres are the protective caps on the ends of the strands of DNA called chromosomes, which house our genomes. In young humans, telomeres are about 8,000-10,000 nucleotides long. They shorten with each cell division, however, and when they reach a critical length the cell stops dividing or dies. This internal “clock” makes it difficult to keep most cells growing in a laboratory for more than a few cell doublings.
Potential uses for therapy
“This new approach paves the way toward preventing or treating diseases of aging,” said Blau. “There are also highly debilitating genetic diseases associated with telomere shortening that could benefit from such a potential treatment.”
Blau and her colleagues became interested in telomeres when previous work in her lab showed that the muscle stem cells of boys with Duchenne muscular dystrophy had telomeres that were much shorter than those of boys without the disease. This finding not only has implications for understanding how the cells function — or don’t function — in making new muscle, but it also helps explain the limited ability to grow affected cells in the laboratory for study.
originally posted by: InFriNiTee
a reply to: bubbabuddha
I know that doctors consider Diabetes of both types to be an "aging disease." I hope something like this becomes available to diabetics (like me). I do not expect this to become available to the masses, but one can hope...
The question for me will be , what will happen when immorality could be realized into humans?
That would be a concern if the therapy altered telomerase expression permanently. it doesn't. this activity ceases when they stop administering the therapy. so if you had say a precancerous cell that only lacked the telemerase mutation common to many cancers it would still lack that mutation after the therapy stopped. the telmerase gene is not in the telomere it is in the regular genetic codes in the working/coding parts of the chromosome.
originally posted by: Semicollegiate
Borderline cells that start reproducing make cancer more likely.
I would want to beef up my immune system before doing telomere therapy.
And get a lot of cancer screens.
originally posted by: InFriNiTee
a reply to: bubbabuddha
I know that doctors consider Diabetes of both types to be an "aging disease." I hope something like this becomes available to diabetics (like me). I do not expect this to become available to the masses, but one can hope...
originally posted by: stormbringer1701
That would be a concern if the therapy altered telomerase expression permanently. it doesn't. this activity ceases when they stop administering the therapy. so if you had say a precancerous cell that only lacked the telemerase mutation common to many cancers it would still lack that mutation after the therapy stopped. the telmerase gene is not in the telomere it is in the regular genetic codes in the working/coding parts of the chromosome.
originally posted by: Semicollegiate
Borderline cells that start reproducing make cancer more likely.
I would want to beef up my immune system before doing telomere therapy.
And get a lot of cancer screens.